Bleomycin in testicular cancer: Will pharmacogenomics improve treatment regimens?

被引:38
作者
Bokemeyer, Carsten [1 ]
机构
[1] Univ Hamburg, Univ Med Ctr Eppendorf, Hamburg, Germany
关键词
D O I
10.1200/JCO.2007.15.2991
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1783 / 1785
页数:3
相关论文
共 13 条
[1]   Bleomycin lung toxicity: who are the patients with increased risk? [J].
Azambuja, E ;
Fleck, JF ;
Batista, RG ;
Barreto, SSM .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (05) :363-366
[2]   Human bleomycin hydrolase: Molecular cloning, sequencing, functional expression, and enzymatic characterization [J].
Bromme, D ;
Rossi, AB ;
Smeekens, SP ;
Anderson, DC ;
Payan, DG .
BIOCHEMISTRY, 1996, 35 (21) :6706-6714
[3]  
Chen XL, 2003, ACTA PHARMACOL SIN, V24, P697
[4]   Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors:: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T9313P) [J].
Culine, S. ;
Kerbrat, P. ;
Kramar, A. ;
Theodore, C. ;
ChevreauU, C. ;
Geoffrois, L. ;
Bui, N. B. ;
Peny, J. ;
Caty, A. ;
Delva, R. ;
Biron, P. ;
Fizazi, K. ;
Bouzy, J. ;
Droz, J. P. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :917-924
[5]   Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer [J].
de Haas, Esther C. ;
Zwart, Nynke ;
Meijer, Coby ;
Nuver, Janine ;
Boezen, H. Marike ;
Suurmeijer, Albert J. H. ;
Hoekstra, Harald J. ;
van der Steege, Gerrit ;
Sleijfer, Dirk Th. ;
Gietema, Jourik A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1817-1823
[6]   Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer:: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medical research council [J].
de Wit, R ;
Roberts, JT ;
Wilkinson, PM ;
de Mulder, PHM ;
Mead, GM ;
Fosså, SD ;
Cook, P ;
de Prijck, L ;
Stenning, S ;
Collette, L .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1629-1640
[7]   Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: Interpretation of the current body of knowledge [J].
de Wit, Ronald .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4346-4349
[8]   Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group [J].
deWit, R ;
Stoter, G ;
Kaye, SB ;
Sleijfer, DT ;
Jones, WG ;
Huinink, WWT ;
Rea, LA ;
Collette, L ;
Sylvester, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1837-1843
[9]   LACK OF METABOLISM AS THE BIOCHEMICAL BASIS OF BLEOMYCIN-INDUCED PULMONARY TOXICITY [J].
LAZO, JS ;
HUMPHREYS, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (10) :3064-3068
[10]  
LAZO JS, 1982, CANCER RES, V42, P4026